Krystexxa (pegloticase) is a recombinent porcine-like uricase used to treat chronic gout. Gout is a kind of arthritis caused when there is too much uric acid in the body. Krystexxa metabolises (converts) uric acid to a water-soluble compound called allantoin, which your body can eliminate easily. Krystexxa can lower uric acid levels very quickly, and dissolve gout build-up over time.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.